Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tiangong Lu
Observed names:
Lu, Tiangong,
T. Lu
Institution:
Beijing University of Chinese Medicine
Observed institutions:
University of Nottingham,
University of South Australia,
Beijing University of Chinese Medicine,
University of Michigan,
U-M Rogel Cancer Center
ORCID:
0000-0002-4521-338X
Observed ORCID:
0000-0002-4521-338X
OpenAlex ID:
A5081647429
Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3
2019
·
Tiangong Lu
, Armand Bankhead
, et al.
·
Theranostics
·
60
Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer
2020
·
Tiangong Lu
, Jianming Tang
, et al.
·
Theranostics
·
42
PDF
Discovery of (E)-3-((Styrylsulfonyl)methyl)pyridine and (E)-2-((Styrylsulfonyl)methyl)pyridine Derivatives as Anticancer Agents: Synthesis, Structure–Activity Relationships, and Biological Activities
2014
·
Tiangong Lu
, Aik Wye Goh
, et al.
·
Journal of Medicinal Chemistry
·
39
In Vitro Antitumor Mechanism of (E)-N-(2-methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)pyridin-3-yl)methanesulfonamide
2014
·
Tiangong Lu
, Charles A. Laughton
, et al.
·
Molecular Pharmacology
·
32
Integrated transcriptomic and proteomic analysis reveals Guizhi-Fuling Wan inhibiting STAT3-EMT in ovarian cancer progression
2023
·
Qihong Ma
, Fangfang Chen
, et al.
·
Biomedicine & Pharmacotherapy
·
13
Lipidation of a bioactive cyclotide-based CXCR4 antagonist greatly improves its pharmacokinetic profile in vivo
2023
·
Dipankar Chaudhuri
, Tiangong Lu
, et al.
·
Journal of Controlled Release
·
12
PDF
Synthesis, ADMET Properties, and Biological Evaluation of Benzothiazole Compounds Targeting Chemokine Receptor 2 (CXCR2)
2017
·
Wesam E. Mehanna
, Tiangong Lu
, et al.
·
ChemMedChem
·
9
The anti-cancer mechanism of Celastrol by targeting JAK2/STAT3 signaling pathway in gastric and ovarian cancer
2024
·
Kang Wu
, Chentao Qiu
, et al.
·
Toxicology and Applied Pharmacology
·
8
Guizhi-Fuling Wan suppresses carcinoma-associated mesenchymal stem cells-induced ovarian cancer progression via STAT3 inhibition
2025
·
Mengwei Xue
, Zixuan Bu
, et al.
·
Phytomedicine
·
4
Guizhi-Fuling formula inhibits ovarian cancer progression by targeting STAT3 signaling network
2021
·
Qihong Ma
, Shi Dong
, et al.
·
TMR Modern Herbal Medicine
·
2
Synthesis and biological evaluation of novel anti-tumour (E)-styrylsulfonyl methylpyridines
2014
·
Tiangong Lu
·
Nottingham ePrints (University of Nottingham)
·
1
PDF
Abstract 3406: Evaluation of (E)-Styrylsulfonyl methylpyridine: A novel kinase inhibitor targeting mitotic pathways.
2013
·
Tiangong Lu
, Shudong Wang
, et al.
·
Cancer Research
·
1
430 Design and structure–activity relationships of highly potent and bioavailable imidazolinone FASN KR domain inhibitors
2014
·
G. Bignan
, R. Alexander
, et al.
·
European Journal of Cancer
CCDC 947538: Experimental Crystal Structure Determination
2014
·
Lu, Tiangong
, Goh, Aik Wye
, et al.
·
The Cambridge Structural Database
Show more works
View as search
Works count:
14
Citation count:
223
H-index:
8
I10-index:
6
Year
Topic
Type